Hypoxia-inducible factor-2α (HIF-2α) mediates the effects of hypoxia on the promotion of HeLa cell viability, colony formation, and invasion capacity in vitro

Genetics and Molecular Research

Volumn 14, Issue 2, 2015, Pages 3281-3292

  Xiong, J ^a   Zhu, F F ^a   Nie, M F ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cell viability; Colony formation; HeLa cells; Hypoxia inducible factor 2a; ShRNA; Transwell invasion

Indexed keywords

CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 2ALPHA; VASCULOTROPIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; VASCULOTROPIN A;

ARTICLE; CELL GROWTH; CELL HYPOXIA; CELL INVASION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; GENE EXPRESSION; GENE SILENCING; HELA CELL LINE; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR PROMOTION; UTERINE CERVIX CANCER; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HUMAN; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR INVASION; TUMOR STEM CELL ASSAY;

LENTIVIRUS;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HELA CELLS; HUMANS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR STEM CELL ASSAY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927617196     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.April.13.7     Document Type: Article

References (31)

1. Armstrong EP (2010). Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J. Manag. Care Pharm. 16: 217-230.
2. Benizri E, Ginouvès A and Berra E (2008). The magic of the hypoxia-signaling cascade. Cell. Mol. Life Sci. 65: 1133-1149.
3. Brahimi-Horn MC and Pouysségur J (2005). The hypoxia-inducible factor and tumor progression along the angiogenic pathway. Int. Rev. Cytol. 242: 157-213.
4. Brizel DM, Dodge RK, Clough RW and Dewhirst MW (1999). Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother. Oncol. 53: 113-117.
5. Cheng J and Fan XM (2013). Role of cyclooxygenase-2 in gastric cancer development and progression. World J. Gastroenterol. 19: 7361-7368.
6. Ema M, Taya S, Yokotani N, Sogawa K, et al. (1997). A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. U. S. A. 94: 4273-4278.
7. Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, et al. (2010). Regulation of human metabolism by hypoxia-inducible factor. Proc. Natl. Acad. Sci. U. S. A. 107: 12722-12727.
8. Franovic A, Holterman CE, Payette J and Lee S (2009). Human cancers converge at the HIF-2αlpha oncogenic axis. Proc. Natl. Acad. Sci. U. S. A. 106: 21306-21311.
9. Gordan JD, Bertout JA, Hu CJ, Diehl JA, et al. (2007). HIF-2αlpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11: 335-347.
10. Griffiths EA, Pritchard SA, McGrath SM, Valentine HR, et al. (2008). Hypoxia-associated markers in gastric carcinogenesis and HIF-2 alpha in gastric and gastro-oesophageal cancer prognosis. Br. J. Cancer 98: 965-973.
11. Höckel M, Schlenger K, Knoop C and Vaupel P (1991). Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res. 51: 6098-6102.
12. Imamura T, Kikuchi H, Herraiz MT, Park DY, et al. (2009). HIF-1alpha and HIF-2αlpha have divergent roles in colon cancer. Int. J. Cancer 124: 763-771.
13. Jhang JF, Jiang YH and Kuo HC (2013). Adding cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms. Int. J. Clin. Pract. 67: 1327-1333.
14. Kawanaka T, Kubo A, Ikushima H, Sano T, et al. (2008). Prognostic significance of HIF-2αlpha expression on tumor infiltrating macrophages in patients with uterine cervical cancer undergoing radiotherapy. J. Med. Invest. 55: 78-86.
15. Kim WY, Perera S, Zhou B, Carretero J, et al. (2009). HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J. Clin. Invest. 119: 2160-2170.
16. Kim MK, Kim TJ, Sung CO, Choi CH, et al. (2011). Clinical significance of HIF-2αlpha immunostaining area in radioresistant cervical cancer. J. Gynecol. Oncol. 22: 44-48.
17. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, et al. (2002). Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53: 1192-1202.
18. Loboda A, Jozkowicz A and Dulak J (2010). HIF-1 and HIF-2 transcription factors-similar but not identical. Mol. Cells 29: 435-442.
19. Lowy DR and Schiller JT (2006). Prophylactic human papillomavirus vaccines. J. Clin. Invest. 116: 1167-1173.
20. Mayer A, Hoeckel M, von Wallbrunn A, Horn LC, et al. (2010). HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomas. Adv. Exp. Med. Biol. 662: 399-405.
21. Nagoya H, Futagami S, Shimpuku M, Tatsuguchi A, et al. (2014). Apurinic/apyrimidinic endonuclease-1 is associated with angiogenesis and VEGF production via upregulation of COX-2 expression in esophageal cancer tissues. Am. J. Physiol. Gastrointest. Liver Physiol. 306:G183-G190.
22. Patel SA and Simon MC (2008). Biology of hypoxia-inducible factor-2alpha in development and disease. Cell. Death Differ. 15: 628-634.
23. Qing G and Simon MC (2009). Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes. Curr. Opin. Genet. Dev. 19: 60-66.
24. Seidel S, Garvalov BK, Wirta V, von Stechow L, et al. (2010). A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 133: 983-995.
25. Shafie NH, Mohd Esa N, Ithnin H, Md Akim A, et al. (2013). Preventive inositol hexaphosphate extracted from rice bran inhibits colorectal cancer through involvement of Wnt/β-catenin and COX-2 pathways. BioMed Res. Int. 2013: 681027.
26. Toschi A, Lee E, Gadir N, Ohh M, et al. (2008). Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J. Biol. Chem. 283: 34495-34499.
27. Tsao CC, Teh BT, Jonasch E, Shreiber-Agus N, et al. (2008). Inhibition of Mxi1 suppresses HIF-2 alpha-dependent renal cancer tumorigenesis. Cancer Biol. Ther. 7: 1619-1627.
28. Turner KJ, Moore JW, Jones A, Taylor CF, et al. (2002). Expression of hypoxia-inducible factors in human renal cancer: Relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res. 62: 2957-2961.
29. Warnecke C, Weidemann A, Volke M, Schietke R, et al. (2008). The specific contribution of hypoxia-inducible factor-2alpha to hypoxia gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp. Cell. Res. 314: 2016-2027.
30. Zhulin IB, Taylor BL and Dixon R (1997). PAS domain S-boxes in Archaea, Bacteria and sensors for oxygen and redox. Trends Biochem. Sci. 22: 331-333.
31. Zimmer M, Lamb J, Ebert BL, Lynch M, et al. (2010). The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2. Cancer Res. 70: 3071-3079.